Qlik Survey Shows “Data to Insights” Leaders See 23% Increase in Revenue Through DataPipeline Optimization

Qlik Survey Shows “Data to Insights” Leaders See 23% Increase in Revenue Through DataPipeline Optimization

New Delhi, September 3, 2020 – Qlik® today launched two new resources that build on the recent global IDC study sponsored by Qlik. The study shows organizations that invest in creating data-to-insights (D2I) capabilities through modern data and analytics pipelines are seeing significant gains. Through the new IDC hosted assessment tool (www.D2I-Score.com), every organization can evaluate the strengths and gaps in their own data pipelines. The tool also provides a set of recommendations that will help organizations better support and focus on strategic investments that can have a significant bottom-line impact. 

“Indian organizations are missing a crucial opportunity to impact their performance by turning data into ongoing business value due to gaps in leaky data pipelines,” said Varun Babbar, Country Manager, Qlik India. “Qlik’s unique end-to-end approach to data integration and analytics can help any organization act at the speed of data through improved data-to-insights capabilities that drive tangible business outcomes.”

The overall survey of 1,200 business leaders show there are key differences in how each country is approaching data pipelines and their D2I capabilities, and how those approaches are impacting business performance.

·         The average D2I score is 41.8 across Asia Pacific. India showed the highest overall score at 47.4, with Australia close behind at 42.4. Singapore and Japan carried the lowest scores at 38.8 and 38.5, respectively.

·         Virtually every company surveyed across Asia Pacific reported a significant challenge in identifying which data sources were valuable. Singapore recorded the highest rate of this challenge (100%), followed by India (98%), Australia (97%), and Japan (89%).

·         The greatest challenges for Indian organizations in capturing data and moving it for processing are ensuring all relevant data is captured (53%), transferring data in a timely manner (46%), and ensuring data quality (45%)

·         The greatest pain points for Indian organizations in processing data into an analytics-ready form are refreshing and updating data correctly (53%), assuring data correctness (49%), and dealing with missing and incomplete data issues (47%).

·         When it came to executing data analytics, presenting analytics in a clear and persuasive form (55%) and conducting the appropriate analytics for the issue being examined (52%) remains the two main pain points among Indian organizations.

·         Improved operational efficiency (81%), customer satisfaction/loyalty (81%), and profit (78%) were the most commonly reported improvements experienced by Indian organizations as a result of investments in data management and analytics.

Varun Babbar, Country Director, Indian Subcontinent at Qlik, continued, “Today, the most common challenges Indian organizations face are flawed analysis, data accessibility issues, and unrealistic targets. We have already seen how the right investments in robust data architectures and data literacy training can bring higher operational efficiency, customer satisfaction, and profit to any business. Companies should, therefore, implement this practice and inspire others to follow suit.”

Regardless of the regional differences, every organization is inundated with complex and varied data types. Many are struggling to maximize the value of that data since it’s flowing through unintegrated and leaky data pipelines, often due to a lack of a data catalog and change data capture capabilities. In addition, investments in AI and analytics are being undercut without an agile, automated and agnostic data pipeline that continually transforms data from any cloud, system or source into enterprise-ready information that drives action and outcomes.

Additionally, a new Qlik data analytics application titled “Data as the New Water: The Importance of Investing in Data and Analytics Pipelines” provides a detailed geographic breakdown of the significant differences in how respondents in key markets such as the US, UK, Brazil, Australia, Singapore and Japan are positioned to either reap the benefits or fall behind competitors based on the strength of their data pipelines.

Qlik’s data integration and data analytics platforms, together with its data literacy as a service offering, deliver the industry’s only end-to-end approach to Active Intelligence. Unlike traditional BI, Active Intelligence realizes the potential in data pipelines by bringing together data at rest with data in motion for continuous intelligence derived from real-time, up-to-date information, and is specifically designed to take or trigger immediate actions. This eliminates data leaks by closing the gaps from relevant to actionable data (Qlik Data Integration), actionable data to actionable insights (Qlik Analytics) and from investment to value (Data Literacy as a Service).

ASUS marks a new beginning; announces foray into commercial PC category

As a top global tech brand, ASUS has a legacy of being the No.1 motherboard brand in the world. It is also known for manufacturing the world’s best PCs, monitors, graphics cards and routers. Passionate about technology and driven by innovation, the company is an experienced leading industry player, ranking No.1 in consumer notebook brand in Asia Pacific and No.3 in worldwide sales. It was also the first global IT company in the world to achieve EU Ecolabel certification for laptops, and achieved 72,477 similar labels globally. ASUS has also been named as the top 10 World’s Most Admired Companies by Fortune Magazine in 2019 for its contribution to the computer industry. The company currently has more than 17,000 employees, including 5000 employees working in the R&D team.

Abbott’s Once-A-Day Ivabradine Receives DCGI Approval for Heart Failure and Angina patients

• Approval marks the first once-a-day formulation for Ivabradine in India, which will help increase adherence to therapy for chronic heart failure and chronic stable angina
• It is estimated that 1.3 to 4.6 million people suffer from heart failure, with 0.5–1.8 million new cases per year in India
• Formulation developed in Abbott’s Innovation and Development center in India based on physician insights on the need for a convenient dosing
• Abbott’s approval is based on data from a phase 3 clinical trial

Delhi, India, 3rd September 2020 — The global healthcare company Abbott today announced that it has received approval from the Drugs Controller General of India (DCGI) for its Ivabradine, once-a-day formulation. For chronic conditions such as cardiac diseases in India, adherence to a treatment is typically low , and when medicines have to be taken multiple times a day, convenience becomes a key patient need. To address this unmet need for more convenient dosing, Abbott developed India’s first “once daily” prolonged-release (PR) version of Ivabradine indicated for patients with chronic heart failure and chronic stable angina. This formulation will be more convenient for patients, which will help facilitate treatment adherence with the aim to improve health outcomes. Abbott plans to launch the Ivabradine PR tablets in the Indian market in the coming weeks.

In India, estimates of people with heart failure range between 1.3 and 4.6 million, with 0.5–1.8 million new cases recorded every year . According to the Global Burden of Disease study, an estimated 14.4 million men and 7.7 million women have lost their productive years to coronary heart disease-related disability .

While the burden of the disease is high in the country, non-adherence to treatment remains a key challenge. Studies have found that many people with cardiac disease in India don’t take their medicines as prescribed by their doctor and an AIIMS study estimates that non-adherence to medication ranges from 24% for people with cardiac disease to 50%-80% for people with hypertension .

With its new formulation, Ivabradine PR tablets can be prescribed as a once-a-day medicine compared to the multiple dosing generally required by patients for the management of the disease. A phase 3 clinical study conducted by Abbott across 21 centers in India, the first of its kind to be conducted for this formulation, showed Ivabradine PR once-a-day formulation to be comparable with the conventional Ivabradine twice-a-day, in the management of patients with stable chronic heart failure, with comparable efficacy and safety profile.

Talking about Ivabradine as a therapy for heart failure patients, Dr. Bharat Chanana, MD, DM CARD, Maharaja Agrasen Hospital explains, “45% of patients suffering from heart failure have a high heart rate with about 40% being hospitalized. The new once daily formulation of Ivabradine will facilitate patient adherence to treatment by reducing the pill burden. This will help control their heart rate and thus reduce hospitalization and improve quality of life.”

This formulation has been developed at Abbott’s Innovation & Development (I&D) center in Mumbai. The I&D center is an important global innovation hub for Abbott’s pharmaceutical business. Researchers at the I&D center use local insights to anticipate patient needs. These insights are linked with existing and innovative technologies to deliver meaningful innovation. Insights from physicians revealed the need for a simpler, more convenient dosing for Ivabradine, which led to the once-a-day solution.
Commenting on the new formulation, Abbott’s Regional Medical Director, Dr. Balagopal Nair, said, “Our goal is to improve health by enhancing medicines to meet patients’ unmet medical needs. Adherence to therapy is a critical factor to maximize the overall health of people with chronic heart failure or chronic stable angina. We have used the best technology and science to develop this new dosage formulation. The convenient once-a-day formulation will help improve overall treatment adherence, leading to better health outcomes.”

Chronic heart failure is a progressive condition in which the heart is unable to pump sufficiently to maintain blood flow to meet the body’s demands for oxygen. Chronic stable angina usually occurs due to obstruction or spasm of the arteries that supply blood to the heart muscle. Ivabradine helps maintain a stable heart rate and prevent it from spiking, which is an important prerequisite in reducing symptoms and in improving the prognosis of both conditions.

Nine schools from India key part in the world’s biggest grassroots online education conference

A selection of nine outstanding Indian schools, from kindergarten and primary level to senior secondary, have been selected for a ground-breaking new grassroots education event – World Education Week – to be held online in October.

Each school is to play a starring role in what is billed as the ‘world’s biggest education conference’, a key ingredient in a showcase of 100 schools which will gather online to share expertise and best practices in the inaugural World Education Week, from 5-9th October, in support of the United Nations Sustainable Development Goal on Quality Education (SDG 4).

A hundred schools have been hand-picked for their expertise across a range of educational themes, such as enhancing employability and life-skills; deepening family and community engagement; the use of technology; a focus on wellbeing; and promoting the science of learning and teaching. Each will share their wisdom to an online audience expected to reach 100,000 worldwide. The ambition driving World Education Week is to accelerate progress to achieve UN SDG 4, a commitment designed to ensure inclusive and equitable quality education and lifelong learning for all.

The Indian schools are:

The TSWRS Chevella Freedom School in Moinabad, Rangareddy

The School of Excellence in Khichripur, New Delhi

Choitram School, in Indore, Madya Pradesh

Mahatma Vidyalaya in Muthanallur, Bangalore District, Karnataka

The iTeach RSM English Medium Secondary School in Mundhwa, Pune

The Government Primary School near Udaipur, Rajasthan

The Riverside School in Ahmedabad, Gujurat

Samaritan Mission School (High) in Howrah, Kolkata

Zilla Parishad Primary School, Kallekhetpada, in the Nandurbar district, Maharashtra

Centred on the theme of ‘Learning Today’, each school will host a virtual event to demonstrate how to bring change, based on their own experiences.

“Mental Health of millions is affected by COVID-19 Pandemic – Here’s how one can seek help from these platforms”

For many people, the lack of social interaction caused by the pandemic has had a profound effect on their mental health. People have suffered from severe anxiety, lifestyle disorders, depression, insomnia, work-related stress, and loneliness before as well, which leads to self-doubt and self-harm, the pandemic and the lockdown have only brought these issues to the surface. While social distancing and self-isolation is at its peak, the need for mental help is more evident than ever.

The importance of mental health is more than ever, and urges the need for quality mental health care in the country as more and more players enter this space. Most importantly, this is essential for the country’s long term growth, wellbeing and economy, since the wellbeing of people contributes greatly to economic and social productivity.

Many industry experts also believe that the demand for such service is only going to increase given
the uncertainty caused due to Covid-19. We have listed down five platforms which are working towards the welfare of mental health in India.

Here are five platforms which are providing mental health and de-addiction services to make it easy for one who’s seeking for help:

Sukoon Health Hospital, established in February 2020, is India’s first specialized hospital for Mental Health and De-Addiction. Founded by two young Social entrepreneurs Vidit Bahri and Kanishk Gupta – Sukoon offers comprehensive treatment for the full spectrum of Mental Health related conditions. It combines cutting edge technology with unparalleled patient care to provide the best clinical care in the country. To assure quality, the clinical program at Sukoon is managed by Fortis Mental Health.

The facility is spread across 15000 sq/ft and designed in accordance with the American Psychiatric Association (APA) standards. It specializes in acute psychiatric hospitalization and ensures seamless treatment through its integrated network of over 20 clinicians. The facility is equipped with 3
psychiatric ICUs, a first of its kind in India, and end-to-end self-harm prevention technology. Sukoon’s tele-counseling service is also available not just for patients but anyone who is feeling anxious, depressed or helpless at home during the COVID-19 Pandemic.

YourDOST , a platform which is a way to connect those who are suffering from mental illnesses with mental health experts. It has been offering counselling in relationships, self-improvement, well-being, education, and career, ever since its inception in 2014. With the option to stay anonymous during chat, phone, or video call sessions, there is an escalated level of comfort that individuals have when
seeking help.

Wysa is essentially an AI (artificial intelligence) chatbot created to address mental health concerns.
This innovative idea to enable mental health welfare in the country came from Jo Aggarwal in 2015. The chatbots are designed by coaches, users, AI experts and therapists to ensure an effective and credible experience. In the current times, Wysa is providing support to those who have been subject
to anxiety and vulnerability.

Trijog, a mumbai-based holistic mental wellness platform that provides access to emotional and mental wellness solutions to individuals, corporates, educational institutes, enterprises etc. Specifically designing a way to keep Indians mentally healthy in times of the COVID-19 crisis, Trijog is currently providing discounted solutions for people facing increased mental difficulties. It has the provision of webinars and online counselling too. It is also affiliated with the Rehabilitation Council
of India.

Innerhour is a startup founded by Dr Shefali Batra and Dr Amit Mailk in 2016. The app launched by them is a wholesome guide that has been curated by mental health professionals with the right attitude, values, and skill set. The app, which can be used by anyone over the age of 18, is a tool for customised self-help, and provides digital therapy – a bonus, especially in the times of a pandemic.

Based in Mumbai,

Innerhour empowers people to overcome mental and emotional hardships. Their goal is to ensure that all users find themselves happier and healthier. The team comprises psychologists, product designers, and developers.

This Teachers Day – Five Edtech Portals which can act as teachers for children during COVID 19 Pandemic

Globally, the closure of schools and educational institutions has affected almost 600 million learners across the world. COVID 19 pandemic has turned education system upside down and boosted remote learning process.

Hence, the EdTech platforms came into play to provide solutions to millions of students in India and helping them with their studies as well as keeping them safe from the deadly COVID-19. Also, these portals are catering to all age groups of children starting from 3 to 16+.

So, this Teachers Day we have listed five EdTech platforms that are helping students to easily study at home or acquire a new skill:

Vedantu :- Vedantu Learn Live Online is one of India’s leading online tutoring website that covers the whole syllabus ranging from CBSE, ISCE, NTSE, Olympiads, and even IIT JEE. Vedantu is offering free online classes on its website and through its app in order to keep students safe inside their homes. The website also offers free study material, apart from the online classes. The website has given a free access to all live classes and content of Vedantu for Grades 1 to 12, JEE & NEET. The online classes can be accessed via their website and on their app that is available for free on Android and iOS.

BeSingular.com – BeSingular is an EdTech platform to skill the next generation, create real, responsible impact through working with the technologies of the future. It’s age graded curriculum, which is curated using the best minds, is built to make students(Age 8-16 yrs) be fearlessly exploratory, big dreamers, progressive, dynamic, and futuristic. The programs at BeSingular focus on teaching Exponential Technologies including Artificial Intelligence (AI), Programming, Robotics, Game Design, Embedded Systems, 3D printing, and Augmented & Virtual Reality (AR, VR). BeSingular impart these programs via offline & Online mode along with live projects focused on solving real world challenges and are curated by technologists and global experts. Established in May 2019 and founded by Mr. Nitesh Jain, he believes in having the ability to shape young kids’ imagination by helping them adapt to the future of technology and solve humanity’s biggest challenges. BeSingular’s Massive Transformative Purpose (MTP) is ‘Transforming education ecosystem to impact the learning possibilities of the next generation.’

Flintoclass@HOME – A preschool-at-home model designed to deliver high-quality preschool education to the homes of children during the COVID-19 pandemic. The easy-to-use comprehensive preschool kit ensures that children continue their early education from the safety and comfort of their homes. Currently, it includes programs for 1.5-5.5 year olds and follows a blended learning approach with pre-recorded interactive sessions and hands-on activities. The all-inclusive monthly kit gets delivered with multi-sensory learning experiences, daily activities, step-by-step instructions, revision materials and even a dashboard to track every child’s daily progress. Flinto believes that given the right tools, every child has the ability to bloom and grow to his/her fullest capacity. And that’s why they take their design process very seriously. All the products and learning tools are intensively researched, developed and assessed at India’s first and only R&D Centre for early education — Flinto Early Learning Research Foundation, by a team of child psychologists, pedagogy experts, curriculum developers and game designers. The research centre collaborates with parents and early educators to create an ecosystem that is conducive for harnessing the true potential in every child.

Brainly – It is one of the largest online learning platforms, uniting students with fellow students, parents, and teachers around the world to help solve their academic problems and to facilitate knowledge exchange. It has a user base of over 25million in India. Here, it connects users to their peers to help strengthen their skills, from math to science, history, and beyond for free.

Byju’s – It is India’s most loved learning app for anyone from the first standard to a higher education aspirant. Engaging video lessons, study material mapped to the syllabus, interactive questions and unlimited practice with in-depth analysis inculcates a fun-learning experience, keeping the interest and longer retention period intact. You may buy a course as per the personal requirement. This EduTech platform makes the learning and understanding of concepts much easier for school kids. The subject focus of the platform is Maths and Science, and the concepts are explained using 12-20 minute digital animation videos.

Dr. Reddy’s Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the U.S. Market

Hyderabad, India and Princeton, NJ, USA. September 3, 2020 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg, a therapeutic equivalent generic version of Concerta® (methylphenidate Hydrochloride) Extended-Release Tablets, 18 mg, 27 mg, 36 mg, and 54 mg, approved by the U.S. Food and Drug Administration (USFDA).

The Concerta® brand and generic market had U.S. sales of approximately $1.159 billion MAT for the most recent twelve months ending in June 2020 according to IQVIA Health*.

Dr. Reddy’s Methylphenidate Hydrochloride Extended-Release Tablets, USP are available in strengths of 18 mg, 27 mg, 36 mg, and 54 mg tablets in bottle count sizes of 100.

Please click here for full prescribing information including boxed warning.

WARNING: DRUG DEPENDENCE

Methylphenidate hydrochloride extended-release tablets should be given cautiously to patients with a history of drug dependence or alcoholism. Chronic abusive use can lead to marked tolerance and psychological dependence with varying degrees of abnormal behaviour.

Frank psychotic episodes can occur, especially with parenteral abuse. Careful supervision is required during withdrawal from abusive use since severe depression may occur. Withdrawal following chronic therapeutic use may unmask symptoms of the underlying disorder that may require follow-up.

Concerta® is a trademark owned or licensed by Janssen Pharmaceuticals, Inc.

*IQVIA Retail and Non-Retail MAT June 2020

RDY-0820-304

Newcastle University excels in a leading guide of global universities

New Delhi, September 03, 2020: The Times Higher Education World University Rankings place Newcastle joint 178th in the world, a rise of more than 20 places from its position in 2019. Areas where Newcastle University scored highly include: International Outlook, which measures the proportion of international staff, proportion of international students and the scale of international co-authorship (ranked 114th globally) and for Citations (ranked 126th).

Professor Chris Day, Vice-Chancellor and President, Newcastle University, UK, said: “There are many ways of assessing our value as a University, and World Rankings are only one measure that can be used to assess the quality, impact and reputation.

“Nevertheless, our strong position in this influential guide is one of the signals of the quality of our research, teaching and employer reputation. I would like to thank academic and professional service colleagues for their hard work and for helping our students to develop the skills needed by employers, especially against the backdrop of this challenging period.”

The latest rankings results are consistent with the University’s strong performance in other international league tables, including the Times Higher Education Impact Rankings, which ranked Newcastle 11th in the world for its impact on society and leadership in sustainable development.

Times Higher Education World University Rankings evaluate five strategic Higher Education areas: teaching, research, citations, industry income and international outlook. The latest rankings guide encompasses 1,527 universities in the world

Zeal Foundation Collaborates with Delhi Government to provide education & nutritional support to Anganwadi kids

New Delhi, 3rd September 2020: In an endeavour to transform and empower children through education, Zeal Foundation, CSR arm of Delhi based air cargo, GSA airlines service provider – Zeal Global, has taken a pledge to extend its help to government and local communities. The foundation has been directing all their efforts to offer food relief for people who are largely affected by this pandemic especially students, kids and families from underprivileged sections of the capital.

The outspread of coronavirus has impacted millions across the world. The disease is paralyzing economies, overburdening healthcare systems, and upending life as we know it. The closure of schools due to the COVID-19 pandemic has obstructed the reliefs meant for children from economically weaker sections of society especially Anganwadi kids aged 3-8 years of age. They have been facing difficulties in accessing basic educational and nutritional services.

Through the collaboration, over 2000 educational and nutritional kits have been distributed to the slum area kids of age 3-6 years. Zeal Foundation identified, 1000 of such vulnerable kids belonging to more than 50 Angagwadi’s in Rajinder Nagar area who have been harshly impacted. The foundation’s efforts are premised on the vision that every child, irrespective of his/her socio-economic conditions has full and equal rights to access proper educational and nutritional support. The 3 centres for the distribution of these kits were – Valmiki Mandir Dusghra village, Chaupal, C Block, Budh Nagar and Sonia Gandhi Camp, Loha Mandi. To the existing relief efforts of the AAP government, the foundation contributed stationery kits comprising a notebook, pencil box, colour set etc. and nutrition packets to ensure sustenance. Under the coronavirus guidelines, the kids were ensured to be given masks and sanitizers beforehand following social distancing.

National Spokesperson and AAP MLA (Rajinder Nagar) Mr. Raghav Chadha, commenting on the distribution stated, “We are facing challenging times with the onset of a pandemic. There are so many students and kids from the Anganwadis that depend on school and meals to nourish their bodies and minds. The COVID-19 pandemic has disrupted all these educational and nutrition-related measures delivered through schools. We are happy to join forces with Zeal Foundation in our on-going relief efforts in Rajinder Nagar Legislative Assembly with the distribution of stationary and nutrition kits to these kids.”

Commenting on the distribution, Nipun Anand, Founder, Zeal Foundation said, “COVID has affected many kids and families especially the ones belonging to underprivileged sections of the society. It’s important that we all come together to help those most in need in this critical time. By supporting the dedicated efforts of the AAP Government who continue providing much-needed access to food and education, we’re helping ensure that the Anganwadi kids can spend more time focusing on their wellbeing and education for a brighter future.”

With the support of the government, the foundation has ensured the continuous need for food resources to these people. Earlier, they distributed more than 10,000 meals to people from underprivileged sections of society in the Rajinder Nagar area.

Mr. Raghav Chaddha also posted the images from today’s distribution at the centres on his personal Instagram handle. Below is the link to the post

https://www.instagram.com/p/CEq1bTMsJer/?utm_source=ig_web_copy_link

A 57-Year-Old Man with respiratory Failure secondary to COVID Induced Lung Fibrosis Successfully Treated at Zen Multispeciality Hospital

Mumbai: A team headed by Dr Arvind Kate, Chest Physician, Zen Multispeciality Hospital, Chembur gives new lease of life to a 57-year-old man from Mumbai who had lung fibrosis due to COVID-19. The patient was in a respiratory failure with high oxygen requirement and his oxygenation was 80% on 15 litres of oxygen. He was treated with oxygen therapy, steroids, Pirfenidone, Bipap, and physiotherapy. The patient can do his daily activities with ease now.

Shravan Oberoi (Name changed), a resident of Chembur, encountered breathing problems in the Month of April. He visited a local doctor who gave medications but nothing seemed to do the trick. Later, his health deteriorated further and the patient was admitted to a hospital in Western Suburb, on June 2. A COVID swab was done on June 10 and he was tested positive for Coronavirus on June 12. He was treated for COVID 19. His family was constantly in touch with him via video calls and phone calls. Again, a COVID swab was done on June 22 and he was declared negative for COVID on June 24. After COVID swab turn negative patient was shifted to Zen Multispeciality Hospital for further management. On arrival to Zen he was in respiratory failure. His CT scan of chest showed extensive lung fibrosis.

Dr Arvind Kate, Chest Physician, Zen Multispeciality Hospital highlighted, “Lung fibrosis can be termed as a lung disease that occurs when lung tissue becomes damaged and scarred. This thickened, stiff tissue makes it difficult for the lungs to function properly. As lung fibrosis worsens, one becomes progressively shorter of breath. When The patient was admitted, he was critical on non-invasive ventilator, oxygen therapy, and in respiratory failure on June 26 at Zen Hospital. He was treated with oxygen therapy, steroids, Pirfenidone, Bipap, and physiotherapy. His was in the ICU for 12days and his condition improved within 3 weeks and was able to do his daily chores by his own. On discharge his oxygen level was 93%. The patient was discharged on July 23 on home oxygen therapy. Post COVID lung fibrosis needs equally efficient treatment in the near future. We may get such patient with POST COVID lung fibrosis. As covid centres are geared up for covid management, non covid centre also require to be equally efficient and receptive to treat post covid lung fibrosis.”

“We panicked after my father was detected with Coronavirus and lung fibrosis. We had been informed he was critical and there were no hopes at all. Due to timely intervention by Zen Hospital, we were hopeful that my father will get back on track. We motivated him through video calling and he was determined to get well soon and come home. Thanks to the doctors who saved his life. Now, he can walk, and does his real-world activities, independently and requires oxygen therapy at home, Doctors are doing online consultation on regular basis to keep a track of my father’s health” said the patient’s son Sachin.